National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

BETHESDA, Md.—The National Cancer Institute has concluded that some of its lymphoma researchers failed to notify the Food and Drug Administration in a timely fashion about fungal infections that resulted in two deaths of patients in one of its research studies. The lab in question has been studying the effects of a cocktail of drugs on an often-fatal and very rare lymphoma of the central nervous system. When two patients died from an infection of a commonly occurring fungus called aspergillus in 2015, the lab and the NCI were supposed…

Read More